3,422 Shares in UnitedHealth Group Incorporated $UNH Bought by Caxton Associates LLP

Key Points

• Caxton Associates LLP acquired 3,422 shares of UnitedHealth Group, valued at approximately $1.79 million, marking a significant investment in the healthcare conglomerate.
• UnitedHealth Group's latest quarterly earnings were $4.08 per share, falling short of analysts' expectations of $4.45, with revenue of $111.62 billion.
• The company announced a quarterly dividend of $2.21 per share, reflecting an annualized yield of 2.8%, with a payout ratio of 38.3%.

Caxton Associates LLP acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 3,422 shares of the healthcare conglomerate's stock, valued at approximately $1,792,000.

Several other institutional investors also recently bought and sold shares of UNH. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares in the last quarter. Copia Wealth Management bought a new position in UnitedHealth Group during the fourth quarter valued at about $42,000. IAG Wealth Partners LLC bought a new position in UnitedHealth Group during the first quarter valued at about $42,000. Finally, Investment Management Corp VA ADV acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $44,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Bank of America lifted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $354.86.

UnitedHealth Group Stock Up 1.6%

NYSE UNH opened at $320.46 on Tuesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock's 50 day moving average is $288.96 and its two-hundred day moving average is $371.54. The company has a market capitalization of $290.24 billion, a price-to-earnings ratio of 13.88, a PEG ratio of 2.04 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.